top of page

PRESS RELEASES

September 28, 2023

Ventripoint’s AI Heart Technology Takes Centre Stage In ITN Business “The Hidden Heart” Programme

September 15, 2023

Ventripoint to Sponsor DGPK Echo Advanced Workshop

September 13, 2023

Ventripoint to Sponsor 51st Annual Nordic Paediatric Cardiology Meeting

September 8, 2023

Ventripoint Announced as Gold Sponsor for the 8th Annual Paediatric Echo Society Symposium

August 30, 2023

Ventripoint Diagnostics Reports Second Quarter 2023 Financial Results

Ventripoint Announces Date and Timing for Release of Q2 2023 Financial Results and Webinar

August 25, 2023

August 22, 2023

Ventripoint Welcomes Evelina London Children’s Hospital as Newest VMS+ User

Ventripoint Unveils New Integrated Product with ASCEND Cardiovascular

August 18, 2023

August 10, 2023

Ventripoint Announces Collaboration with Ascend Cardiovascular 

August 2, 2023

Ventripoint Diagnostics to Attend 8th World Congress of Paediatric Cardiology and Cardiac Surgery 

Ventripoint's VMS+ Purchased by University of Freiburg Medical Center

July 18, 2023

July 11, 2023

Ventripoint to Sponsor Advanced Imaging 2023 in London England

May 30, 2023

Ventripoint Receives European Union Medical Device Regulation Certification

July 5, 2023

Ventripoint Diagnostics Makes Significant Sale to the Largest Heart Center in Germany

May 29, 2023

Ventripoint Announces Date and Webinar Details Regarding First Quarter 2023 Financial Results

May 17, 2023

Ventripoint Issues Option Grants and Reports Exercise of Options

May 2, 2023

Ventripoint Diagnostics Reports Fourth Quarter and Full Year 2022 Financial Results

April 25, 2023

Ventripoint Announces Sponsorship of the 56th Annual Meeting of the Association for European Paediatric and Congenital Cardiology

March 16, 2023

Ventripoint Diagnostics Provides a Corporate Update

January 3, 2023

Ventripoint Diagnostics Announces Dr. Alvira Macanovic as President and CEO

bottom of page